Atrial fibrillation and heart failure represent a growing dual epidemic, each condition amplifying the progression and complexity of the other. This roundtable will explore the bidirectional pathophysiology linking AF and HF, examining evidence-based strategies for screening, rhythm and rate control, guideline-directed medical therapy, and device-based approaches. Participants will leave with a sharper framework for managing this high-risk patient population across the full spectrum of heart failure phenotypes.
Powered by Medtronic
